Portside Wealth Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Buy
+3,844
New +$173K 0.02% 495
2025
Q4
– Sell
-6,093
Closed -$215K – 467
2025
Q3
$215K Sell
6,093
-404
-6% -$13.9K 0.03% 449
2025
Q2
$213K Buy
+6,497
New +$211K 0.03% 429

Other funds holding ATRC

Portside Wealth Group's ATRC Position: Q3 2026 in Review

Portside Wealth Group opened a new position in AtriCure (ATRC) in Q3 2026: 3,844 shares worth $216K. The stake represents 0.02% of the portfolio and ranks #495 among its holdings. This is a return to the name: Portside Wealth Group previously reported a position in ATRC as recently as Q3 2025.

Portside Wealth Group first reported a position in ATRC in Q2 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Portside Wealth Group held 3,844 shares of AtriCure worth $216K as of Q3 2026.
  • AtriCure was a new Portside Wealth Group position in Q3 2026.
  • AtriCure made up 0.02% of Portside Wealth Group's portfolio in Q3 2026, its #495 holding.
  • Portside Wealth Group first reported a position in AtriCure in Q2 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.